Erratum

Errata

This article corrects:

  1. Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia Volume 117, Issue 9, 1800–1811, Article first published online: 29 November 2010

No abstract is available for this article.

Ancillary